506938 — Kappac Pharma Balance Sheet
0.000.00%
HealthcareMicro Cap
Annual balance sheet for Kappac Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2017 March 31st | C2018 March 31st | 2019 March 31st | 2020 March 31st | 2021 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PRESS | Interim Report | PRESS | PRESS | PRESS |
Standards: | — | — | — | — | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 220 | 0.13 | 0.13 | 0.019 | 0.017 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.001 | 1.92 | 46.9 | 196 | 201 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 220 | 2.2 | 47.2 | 196 | 201 |
Net Property, Plant And Equipment | 0 | 0 | 0 | 0 | 0 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 380 | 382 | 434 | 364 | 342 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.491 | 2.53 | 54.9 | 0.574 | 0.704 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.491 | 2.53 | 54.9 | 0.574 | 0.704 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 380 | 380 | 379 | 363 | 341 |
Total Liabilities & Shareholders' Equity | 380 | 382 | 434 | 364 | 342 |
Total Common Shares Outstanding |